Tezepelumab for Atopic Diseases

Apr 10, 2020, 02:15 PM

Headliner
Share
Subscribe
Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.
Share
Subscribe
Next
Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients
Top episodes
What We Know About the Omicron Variant
by HCPLive Podcasts
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD
by HCPLive Podcasts
Cardiology in 2019 with Deepak Bhatt, MD, MPH
by HCPLive Podcasts